SCM
ENTA icon

Sio Capital Management’s Enanta Pharmaceuticals ENTA Stock Holding History

Sio Capital Management’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-40,000
Closed -$505K – 70
2026
Q1 		$505K Hold
40,000
– – 0.07% 65
2025
Q4 		$631K Buy
+40,000
New +$508K 0.1% 61
2025
Q3 		– Sell
-178,774
Closed -$1.35M – 58
2025
Q2 		$1.35M Buy
178,774
+1,770
+1% +$10.6K 0.52% 36
2025
Q1 		$977K Hold
177,004
– – 0.29% 41
2024
Q4 		$1.02M Hold
177,004
– – 0.29% 37
2024
Q3 		$1.83M Hold
177,004
– – 0.73% 24
2024
Q2 		$2.3M Hold
177,004
– – 0.62% 28
2024
Q1 		$3.09M Buy
+177,004
New +$2.34M 0.92% 31

Other funds holding ENTA

JT
Jupiter Topco New York $245B AUM
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
KAM
Krensavage Asset Management New York $263M AUM 66.99% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
ACM
ADAR1 Capital Management Austin, Texas $2.19B AUM 374.99% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $84.2B AUM 55.88% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Sio Capital Management's ENTA Position: Q2 2026 in Review

Sio Capital Management sold out of Enanta Pharmaceuticals (ENTA) in Q2 2026, closing a stake of 40,000 shares — an estimated $505K sold.

Sio Capital Management first reported a position in ENTA in Q1 2024 and held it in 8 quarters. The position peaked at $3.09M in Q1 2024. 123 funds tracked by Wall St. Rank hold ENTA as of Q2 2026.

  • Sio Capital Management reported no remaining Enanta Pharmaceuticals position as of Q2 2026 after selling out during the quarter.
  • Sio Capital Management sold 40,000 Enanta Pharmaceuticals shares in Q2 2026, an estimated $505K.
  • Sio Capital Management first reported a position in Enanta Pharmaceuticals in Q1 2024 and held it in 8 quarters.
  • Sio Capital Management's Enanta Pharmaceuticals position peaked at $3.09M in Q1 2024.
  • 123 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q2 2026.

Based on Sio Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.